Expanding the repertoire of RNA interference screens for developing new anticancer drug targets.
about
Bioenergetics and gene silencing approaches for unraveling nucleotide recognition by the human EIF2C2/Ago2 PAZ domain.Strategies for short hairpin RNA delivery in cancer gene therapy.The promise of mTOR inhibitors in the treatment of colorectal cancer.Development of a high-content screening assay panel to accelerate mechanism of action studies for oncology research.Increased RNAi is related to intracellular release of siRNA via a covalently attached signal peptide.Target discovery screens using pooled shRNA libraries and next-generation sequencing: A model workflow and analytical algorithm.
P2860
Expanding the repertoire of RNA interference screens for developing new anticancer drug targets.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Expanding the repertoire of RN ...... g new anticancer drug targets.
@en
Expanding the repertoire of RN ...... g new anticancer drug targets.
@nl
type
label
Expanding the repertoire of RN ...... g new anticancer drug targets.
@en
Expanding the repertoire of RN ...... g new anticancer drug targets.
@nl
prefLabel
Expanding the repertoire of RN ...... g new anticancer drug targets.
@en
Expanding the repertoire of RN ...... g new anticancer drug targets.
@nl
P2860
P1476
Expanding the repertoire of RN ...... g new anticancer drug targets.
@en
P2093
Steven A Haney
P2860
P304
P356
10.1517/14728222.11.11.1429
P407
P577
2007-11-01T00:00:00Z